194 related articles for article (PubMed ID: 9538966)
1. Optimal time of administration of insulin lispro. Importance of meal composition.
Strachan MW; Frier BM
Diabetes Care; 1998 Jan; 21(1):26-31. PubMed ID: 9538966
[TBL] [Abstract][Full Text] [Related]
2. Postprandial insulin lispro. A new therapeutic option for type 1 diabetic patients.
Schernthaner G; Wein W; Sandholzer K; Equiluz-Bruck S; Bates PC; Birkett MA
Diabetes Care; 1998 Apr; 21(4):570-3. PubMed ID: 9571344
[TBL] [Abstract][Full Text] [Related]
3. Preprandial vs. postprandial insulin lispro-a comparative crossover trial in patients with Type 1 diabetes.
Schernthaner G; Wein W; Shnawa N; Bates PC; Birkett MA
Diabet Med; 2004 Mar; 21(3):279-84. PubMed ID: 15008840
[TBL] [Abstract][Full Text] [Related]
4. Meal composition is a determinant of lispro-induced hypoglycemia in IDDM.
Burge MR; Castillo KR; Schade DS
Diabetes Care; 1997 Feb; 20(2):152-5. PubMed ID: 9118763
[TBL] [Abstract][Full Text] [Related]
5. Postprandial glycaemia after regular and lispro insulin in children and adolescents with diabetes.
Rami B; Schober E
Eur J Pediatr; 1997 Nov; 156(11):838-40. PubMed ID: 9392394
[TBL] [Abstract][Full Text] [Related]
6. Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study.
Weyer C; Gottlieb A; Kim DD; Lutz K; Schwartz S; Gutierrez M; Wang Y; Ruggles JA; Kolterman OG; Maggs DG
Diabetes Care; 2003 Nov; 26(11):3074-9. PubMed ID: 14578242
[TBL] [Abstract][Full Text] [Related]
7. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
[TBL] [Abstract][Full Text] [Related]
8. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.
Jovanovic L; Giammattei J; Acquistapace M; Bornstein K; Sommermann E; Pettitt DJ
Clin Ther; 2004 Sep; 26(9):1492-7. PubMed ID: 15531011
[TBL] [Abstract][Full Text] [Related]
9. Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime.
Ciofetta M; Lalli C; Del Sindaco P; Torlone E; Pampanelli S; Mauro L; Chiara DL; Brunetti P; Bolli GB
Diabetes Care; 1999 May; 22(5):795-800. PubMed ID: 10332684
[TBL] [Abstract][Full Text] [Related]
10. Optimal administration of lispro insulin in hyperglycemic type 1 diabetes.
Rassam AG; Zeise TM; Burge MR; Schade DS
Diabetes Care; 1999 Jan; 22(1):133-6. PubMed ID: 10333914
[TBL] [Abstract][Full Text] [Related]
11. Lispro or regular insulin for multiple injection therapy in adolescence. Differences in free insulin and glucose levels overnight.
Mohn A; Matyka KA; Harris DA; Ross KM; Edge JA; Dunger DB
Diabetes Care; 1999 Jan; 22(1):27-32. PubMed ID: 10333899
[TBL] [Abstract][Full Text] [Related]
12. The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients.
Ahmed AB; Home PD
Diabetes Care; 1998 Jan; 21(1):32-7. PubMed ID: 9538967
[TBL] [Abstract][Full Text] [Related]
13. In children using intensive insulin therapy, a 20-g variation in carbohydrate amount significantly impacts on postprandial glycaemia.
Smart CE; King BR; McElduff P; Collins CE
Diabet Med; 2012 Jul; 29(7):e21-4. PubMed ID: 22268422
[TBL] [Abstract][Full Text] [Related]
14. Metabolic efficacy of preprandial administration of Lys(B28), Pro(B29) human insulin analog in IDDM patients. A comparison with human regular insulin during a three-meal test period.
Jacobs MA; Keulen ET; Kanc K; Casteleijn S; Scheffer P; Devillé W; Heine RJ
Diabetes Care; 1997 Aug; 20(8):1279-86. PubMed ID: 9250454
[TBL] [Abstract][Full Text] [Related]
15. Insulin lispro lowers postprandial glucose in prepubertal children with diabetes.
Deeb LC; Holcombe JH; Brunelle R; Zalani S; Brink S; Jenner M; Kitson H; Perlman K; Spencer M
Pediatrics; 2001 Nov; 108(5):1175-9. PubMed ID: 11694699
[TBL] [Abstract][Full Text] [Related]
16. Pre-meal insulin analogue insulin lispro vs Humulin R insulin treatment in young subjects with type 1 diabetes.
Garg SK; Carmain JA; Braddy KC; Anderson JH; Vignati L; Jennings MK; Chase HP
Diabet Med; 1996 Jan; 13(1):47-52. PubMed ID: 8741812
[TBL] [Abstract][Full Text] [Related]
17. Ultra-rapid BioChaperone Lispro improves postprandial blood glucose excursions vs insulin lispro in a 14-day crossover treatment study in people with type 1 diabetes.
Andersen G; Meiffren G; Lamers D; DeVries JH; Ranson A; Seroussi C; Alluis B; Gaudier M; Soula O; Heise T
Diabetes Obes Metab; 2018 Nov; 20(11):2627-2632. PubMed ID: 29923294
[TBL] [Abstract][Full Text] [Related]
18. Optimal provision of daytime NPH insulin in patients using the insulin analog lispro.
Ahmed AB; Home PD
Diabetes Care; 1998 Oct; 21(10):1707-13. PubMed ID: 9773735
[TBL] [Abstract][Full Text] [Related]
19. Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.
Maggs DG; Fineman M; Kornstein J; Burrell T; Schwartz S; Wang Y; Ruggles JA; Kolterman OG; Weyer C
Diabetes Metab Res Rev; 2004; 20(1):55-60. PubMed ID: 14737746
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of insulin lispro in combination with NPH human insulin twice per day in patients with insulin-dependent or non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.
Vignati L; Anderson JH; Iversen PW
Clin Ther; 1997; 19(6):1408-21. PubMed ID: 9444449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
